应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALGS Aligos Therapeutics, Inc.
休市中 12-05 16:00:00 EST
9.99
-0.10
-0.99%
盘后
9.99
+0.00
0.00%
16:10 EST
最高
10.26
最低
9.84
成交量
3.38万
今开
10.12
昨收
10.09
日振幅
4.11%
总市值
6,147万
流通市值
2,999万
总股本
615.36万
成交额
33.91万
换手率
1.13%
流通股本
300.20万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Aligos Therapeutics获得Usan委员会批准,将Pevifoscorvir Sodium作为Alg-000184的非专有名称
美股速递 · 10-16
Aligos Therapeutics获得Usan委员会批准,将Pevifoscorvir Sodium作为Alg-000184的非专有名称
Aligos Therapeutics, Inc.盘中异动 急速上涨5.54%
市场透视 · 09-24
Aligos Therapeutics, Inc.盘中异动 急速上涨5.54%
Aligos Therapeutics, Inc.盘中异动 早盘大幅拉升7.27%
市场透视 · 08-18
Aligos Therapeutics, Inc.盘中异动 早盘大幅拉升7.27%
Aligos Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%
市场透视 · 08-09
Aligos Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌9.13%
市场透视 · 08-07
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌9.13%
Aligos Therapeutics, Inc.盘中异动 早盘急速下挫7.26%报12.00美元
市场透视 · 03-10
Aligos Therapeutics, Inc.盘中异动 早盘急速下挫7.26%报12.00美元
Aligos Therapeutics 第四季度每股收益 $(13.08) 未达预期,销售额 $629.00 千美元 超出预期
财报速递 · 03-10
Aligos Therapeutics 第四季度每股收益 $(13.08) 未达预期,销售额 $629.00 千美元 超出预期
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.48%
市场透视 · 03-06
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.48%
Aligos Therapeutics, Inc.盘中异动 股价大跌5.02%报16.02美元
市场透视 · 03-04
Aligos Therapeutics, Inc.盘中异动 股价大跌5.02%报16.02美元
Aligos Therapeutics, Inc.盘中异动 下午盘大幅下跌5.07%
市场透视 · 02-28
Aligos Therapeutics, Inc.盘中异动 下午盘大幅下跌5.07%
Aligos Therapeutics, Inc.盘中异动 急速拉升5.31%报18.25美元
市场透视 · 02-26
Aligos Therapeutics, Inc.盘中异动 急速拉升5.31%报18.25美元
Aligos Therapeutics, Inc.盘中异动 股价大跌6.51%报16.66美元
市场透视 · 02-25
Aligos Therapeutics, Inc.盘中异动 股价大跌6.51%报16.66美元
Aligos Therapeutics, Inc.盘中异动 股价大跌5.25%
市场透视 · 02-22
Aligos Therapeutics, Inc.盘中异动 股价大跌5.25%
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报21.64美元
市场透视 · 02-19
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报21.64美元
Aligos Therapeutics, Inc.盘中异动 大幅下挫5.03%报22.48美元
市场透视 · 02-19
Aligos Therapeutics, Inc.盘中异动 大幅下挫5.03%报22.48美元
在所有治疗领域强劲业绩的推动下,益普生2024年实现稳健业绩增长并确认2025年全年指引
美通社 · 02-17
在所有治疗领域强劲业绩的推动下,益普生2024年实现稳健业绩增长并确认2025年全年指引
Aligos Therapeutics, Inc.盘中异动 急速拉升5.43%报22.15美元
市场透视 · 02-14
Aligos Therapeutics, Inc.盘中异动 急速拉升5.43%报22.15美元
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.42%
市场透视 · 02-11
Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.42%
Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报29.09美元
市场透视 · 02-10
Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报29.09美元
Aligos Therapeutics, Inc.盘中异动 下午盘快速上涨5.14%
市场透视 · 02-08
Aligos Therapeutics, Inc.盘中异动 下午盘快速上涨5.14%
加载更多
公司概况
公司名称:
Aligos Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发新疗法,以解决肝病和病毒感染方面未满足的医疗需求。
发行价格:
--
{"stockData":{"symbol":"ALGS","market":"US","secType":"STK","nameCN":"Aligos Therapeutics, Inc.","latestPrice":9.99,"timestamp":1764968400000,"preClose":10.09,"halted":0,"volume":33843,"hourTrading":{"tag":"盘后","latestPrice":9.99,"preClose":9.99,"latestTime":"16:10 EST","volume":19,"amount":189.81,"timestamp":1764969004367},"delay":0,"floatShares":3001986,"shares":6153600,"eps":-9.760614,"marketStatus":"休市中","change":-0.1,"latestTime":"12-05 16:00:00 EST","open":10.12,"high":10.255,"low":9.84,"amount":339144.798003,"amplitude":0.04113,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.760614,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":10.09,"preHourTrading":{"tag":"盘前","latestPrice":10.0125,"preClose":10.09,"latestTime":"08:52 EST","volume":108,"amount":1133.47242,"timestamp":1764942725582},"postHourTrading":{"tag":"盘后","latestPrice":9.99,"preClose":9.99,"latestTime":"16:10 EST","volume":19,"amount":189.81,"timestamp":1764969004367},"volumeRatio":0.46712602252130625,"impliedVol":0.1576,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ALGS","defaultTab":"news","newsList":[{"id":"1199166126","title":"Aligos Therapeutics获得Usan委员会批准,将Pevifoscorvir Sodium作为Alg-000184的非专有名称","url":"https://stock-news.laohu8.com/highlight/detail?id=1199166126","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199166126?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:31","pubTimestamp":1760617871,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics获得Usan委员会批准,将Pevifoscorvir Sodium作为Alg-000184的非专有名称。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","ALGS"],"gpt_icon":0},{"id":"2569174020","title":"Aligos Therapeutics, Inc.盘中异动 急速上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569174020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569174020?lang=zh_cn&edition=full","pubTime":"2025-09-24 00:28","pubTimestamp":1758644889,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日00时28分,Aligos Therapeutics, Inc.股票出现波动,股价急速拉升5.54%。截至发稿,该股报10.06美元/股,成交量3.2389万股,换手率0.47%,振幅5.09%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.06%。其相关个股中,Galecto, Inc.、木薯科学、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃,换手率分别为3697.36%、344.03%、169.39%,振幅较大的相关个股有Adverum Biotechnologies, Inc.、Galecto, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为47.68%、40.33%、38.68%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924002809a6996b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924002809a6996b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALGS","LENZ","BK4505","BK4139","BK4539"],"gpt_icon":0},{"id":"2560082155","title":"Aligos Therapeutics, Inc.盘中异动 早盘大幅拉升7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560082155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560082155?lang=zh_cn&edition=full","pubTime":"2025-08-18 23:07","pubTimestamp":1755529672,"startTime":"0","endTime":"0","summary":"北京时间2025年08月18日23时07分,Aligos Therapeutics, Inc.股票出现波动,股价大幅上涨7.27%。截至发稿,该股报8.26美元/股,成交量2.0424万股,换手率0.29%,振幅5.30%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Soligenix, Inc.、Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.涨幅较大,Soligenix, Inc.、Aspire Biopharma Holdings, Inc.、Propanc Biopharma, Inc.较为活跃,换手率分别为3022.09%、753.76%、435.30%,振幅较大的相关个股有Propanc Biopharma, Inc.、Soligenix, Inc.、Aspire Biopharma Holdings, Inc.,振幅分别为128.92%、95.66%、83.57%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818230752a6ed43fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818230752a6ed43fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","LENZ","BK4505","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2558357600","title":"Aligos Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558357600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558357600?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:10","pubTimestamp":1754673011,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时10分,Aligos Therapeutics, Inc.股票出现波动,股价急速跳水5.01%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Hyperion Defi, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃,换手率分别为629.86%、168.25%、102.32%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为75.81%、73.00%、46.49%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011011a6db6c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011011a6db6c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4505","BK4007","BK4139","ALGS"],"gpt_icon":0},{"id":"2557256180","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌9.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557256180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557256180?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573514,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分,Aligos Therapeutics, Inc.股票出现异动,股价急速下挫9.13%。截至发稿,该股报7.31美元/股,成交量594股,换手率0.01%,振幅0.00%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Palisade Bio, Inc.、Niagen Bioscience, Inc.、Sarepta Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为429.89%、62.21%、21.14%,振幅较大的相关个股有Palisade Bio, Inc.、Xeris制药、Cormedix Inc.,振幅分别为39.00%、12.75%、10.13%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213154a47b24cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213154a47b24cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4505","LENZ","BK4007","ALGS"],"gpt_icon":0},{"id":"2518220020","title":"Aligos Therapeutics, Inc.盘中异动 早盘急速下挫7.26%报12.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220020?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分,Aligos Therapeutics, Inc.股票出现异动,股价快速下挫7.26%。截至发稿,该股报12.00美元/股,成交量2.7267万股,换手率0.76%,振幅3.79%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2096.04%、413.43%、64.56%,振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.,振幅分别为100.05%、99.13%、98.72%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALGS","LENZ"],"gpt_icon":0},{"id":"1169357471","title":"Aligos Therapeutics 第四季度每股收益 $(13.08) 未达预期,销售额 $629.00 千美元 超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1169357471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169357471?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:06","pubTimestamp":1741608360,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics报告季度每股亏损 $,比分析师的共识预期 $ 差 468.7%。公司报告季度销售额为 62.9 万美元,超出分析师共识预期的 43.33 万美元 45.15%。与去年同期销售额 201 万美元相比,这一数据下降了 68.69%。以上内容来自Benzinga Earnings专栏,原文如下:Aligos $Therapeutics$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 468.7 percent. This is a 137.82 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $629.00 thousand which beat the analyst consensus estimate of $433.33 t","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALGS"],"gpt_icon":0},{"id":"2517166112","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166112?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271907,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分,Aligos Therapeutics, Inc.股票出现波动,股价急速下跌5.48%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1107.94%、213.59%、54.76%,振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为31.46%、30.53%、23.12%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALGS","BK4505"],"gpt_icon":0},{"id":"2516065196","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.02%报16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516065196?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:52","pubTimestamp":1741024325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时52分,Aligos Therapeutics, Inc.股票出现异动,股价大幅下跌5.02%。截至发稿,该股报16.02美元/股,成交量4.3923万股,换手率1.22%,振幅6.70%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为4294.62%、178.37%、175.13%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALGS"],"gpt_icon":0},{"id":"2514096332","title":"Aligos Therapeutics, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514096332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:28","pubTimestamp":1740688132,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时28分,Aligos Therapeutics, Inc.股票出现异动,股价急速跳水5.07%。截至发稿,该股报16.85美元/股,成交量14.2729万股,换手率3.98%,振幅9.46%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1927.83%、378.45%、194.99%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALGS","BK4505"],"gpt_icon":0},{"id":"2514856875","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.31%报18.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856875?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分,Aligos Therapeutics, Inc.股票出现异动,股价快速上涨5.31%。截至发稿,该股报18.25美元/股,成交量8681股,换手率0.24%,振幅4.53%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Channel Therapeutics Corporation、Immunoprecise Antibodies Ltd.涨幅较大,Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为127.32%、94.89%、76.22%,振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation,振幅分别为38.41%、17.13%、16.86%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","LENZ","BK4505","BK4139"],"gpt_icon":0},{"id":"2514399090","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌6.51%报16.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514399090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514399090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494235,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分,Aligos Therapeutics, Inc.股票出现异动,股价大幅下挫6.51%。截至发稿,该股报16.66美元/股,成交量8885股,换手率0.25%,振幅3.42%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为793.45%、560.91%、495.53%,振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Adial Pharmaceuticals, Inc,振幅分别为86.72%、26.11%、20.51%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2513904732","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513904732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513904732?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:51","pubTimestamp":1740156706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时51分,Aligos Therapeutics, Inc.股票出现波动,股价大幅下挫5.25%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大,Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为231.30%、161.40%、124.05%,振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.,振幅分别为72.46%、57.50%、48.35%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALGS","BK4505"],"gpt_icon":0},{"id":"2512348185","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报21.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512348185?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:58","pubTimestamp":1739980689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时58分,Aligos Therapeutics, Inc.股票出现异动,股价急速下跌5.05%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。其相关个股中,Osr Holdings Inc C/Wts 02/09/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为556.97%、241.94%、106.27%,振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.,振幅分别为207.68%、48.18%、36.97%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2512178196","title":"Aligos Therapeutics, Inc.盘中异动 大幅下挫5.03%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512178196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512178196?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:19","pubTimestamp":1739906369,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时19分,Aligos Therapeutics, Inc.股票出现异动,股价大幅下挫5.03%。截至发稿,该股报22.48美元/股,成交量9.6674万股,换手率2.69%,振幅7.58%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。其相关个股中,Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大,Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃,换手率分别为845.55%、209.84%、168.60%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.,振幅分别为148.75%、92.00%、79.17%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","LENZ","BK4139"],"gpt_icon":0},{"id":"2512529945","title":"在所有治疗领域强劲业绩的推动下,益普生2024年实现稳健业绩增长并确认2025年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2512529945","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512529945?lang=zh_cn&edition=full","pubTime":"2025-02-17 17:58","pubTimestamp":1739786280,"startTime":"0","endTime":"0","summary":"本年度还与Skyhawk Therapeutics签署了一项合作协议,开发用于治疗罕见神经系统疾病的RNA调节小分子药物。环境、社会和治理 2024年,益普生采取了重要步骤,以实施可持续发展战略的宏伟目标。经过密集转型项目,目前益普生全球99.8%的电力来自可再生能源。2025年财务指引 益普生为2025财年制定了以下财务指引,其中排除了潜在的后期业务开发交易的任何影响: 以固定汇率计算,总销售额增长超过5.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","IPN","BK4080","BK4231","BK4505","BK4139","IPSEY","ADC","ALGS"],"gpt_icon":0},{"id":"2511973346","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.43%报22.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511973346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511973346?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:17","pubTimestamp":1739546241,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时17分,Aligos Therapeutics, Inc.股票出现波动,股价大幅上涨5.43%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cns Pharmaceuticals, Inc.涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2358.95%、615.56%、469.87%,振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.,振幅分别为66.93%、43.67%、40.35%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2510204387","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510204387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510204387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284445,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分,Aligos Therapeutics, Inc.股票出现波动,股价急速跳水5.42%。截至发稿,该股报26.20美元/股,成交量6252股,换手率0.17%,振幅2.17%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃,换手率分别为2013.25%、534.44%、178.65%,振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Akari Therapeutics Plc,振幅分别为25.06%、21.89%、16.07%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALGS","BK4139"],"gpt_icon":0},{"id":"2510869362","title":"Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报29.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510869362?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:08","pubTimestamp":1739200110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时08分,Aligos Therapeutics, Inc.股票出现异动,股价急速拉升5.67%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为2375.57%、1451.34%、906.24%,振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为69.83%、66.09%、39.57%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALGS"],"gpt_icon":0},{"id":"2509727462","title":"Aligos Therapeutics, Inc.盘中异动 下午盘快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509727462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509727462?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:26","pubTimestamp":1738952813,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时26分,Aligos Therapeutics, Inc.股票出现异动,股价快速上涨5.14%。Aligos Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Conduit Pharmaceuticals Inc.、Sionna Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为7709.99%、175.45%、124.43%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为130.43%、93.55%、54.63%。Aligos Therapeutics, Inc.公司简介:Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022653961b6048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022653961b6048&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALGS","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aligos.com","stockEarnings":[{"period":"1week","weight":0.0428},{"period":"1month","weight":0.3629},{"period":"3month","weight":-0.119},{"period":"6month","weight":0.3875},{"period":"1year","weight":-0.6428},{"period":"ytd","weight":-0.7492}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发新疗法,以解决肝病和病毒感染方面未满足的医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002038},{"month":2,"riseRate":0.4,"avgChangeRate":-0.075982},{"month":3,"riseRate":0,"avgChangeRate":-0.248555},{"month":4,"riseRate":0.4,"avgChangeRate":-0.107182},{"month":5,"riseRate":0.4,"avgChangeRate":-0.025878},{"month":6,"riseRate":0.2,"avgChangeRate":-0.103077},{"month":7,"riseRate":0.6,"avgChangeRate":0.030308},{"month":8,"riseRate":0.6,"avgChangeRate":0.114051},{"month":9,"riseRate":0,"avgChangeRate":-0.14617},{"month":10,"riseRate":0.4,"avgChangeRate":-0.048799},{"month":11,"riseRate":0.666667,"avgChangeRate":0.350449},{"month":12,"riseRate":0.5,"avgChangeRate":0.126438}],"exchange":"NASDAQ","name":"Aligos Therapeutics, Inc.","nameEN":"Aligos Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aligos Therapeutics, Inc.,ALGS,Aligos Therapeutics, Inc.股票,Aligos Therapeutics, Inc.股票老虎,Aligos Therapeutics, Inc.股票老虎国际,Aligos Therapeutics, Inc.行情,Aligos Therapeutics, Inc.股票行情,Aligos Therapeutics, Inc.股价,Aligos Therapeutics, Inc.股市,Aligos Therapeutics, Inc.股票价格,Aligos Therapeutics, Inc.股票交易,Aligos Therapeutics, Inc.股票购买,Aligos Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}